Crohn's disease

Citations 11-20 of 732 total displayed.

Leading articles
TPMT in the treatment of Crohn's disease with azathioprine

L Lennard
Gut 2002; 51: 143-146. [Abstract] [Full text] [PDF] [Request Permissions]  

Debate
Crohn's disease recurrence can be prevented after ileal resection

P Rutgeerts
Gut 2002; 51: 152-153. [Extract] [Full text] [PDF] [Request Permissions]  

Debate
Crohn's disease recurrence can be prevented after ileal resection

D S Rampton
Gut 2002; 51: 153-154. [Extract] [Full text] [PDF] [Request Permissions]  

Inflammation and inflammatory bowel disease
Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial

M A Gassull, F Fernández-Bañares, E Cabré, M Papo, M H Giaffer, J L Sánchez-Lombraña, C Richart, H Malchow, F González-Huix, and M Esteve
Gut 2002; 51: 164-168. [Abstract] [Full text] [PDF] [Request Permissions]  

Therapy update
New steroids for IBD: progress report

S B Hanauer
Gut 2002; 51: 182-183. [Extract] [Full text] [PDF] [Request Permissions]  

Debate
Ileal Crohn's disease is best treated by surgery

A C J Windsor
Gut 2002; 51: 11-12. [Extract] [Full text] [PDF] [Request Permissions]  

Debate
Ileal Crohn's disease is best treated by surgery

M J G Farthing
Gut 2002; 51: 13-14. [Extract] [Full text] [PDF] [Request Permissions]  

Inflammatory bowel disease
In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis

S Bridger, J C W Lee, I Bjarnason, J E Lennard Jones, and A J Macpherson
Gut 2002; 51: 21-25. [Abstract] [Full text] [PDF] [Request Permissions]  

Inflammatory bowel disease
Adult height in patients with early onset of Crohn's disease

N Alemzadeh, L T M Rekers-Mombarg, M L Mearin, J M Wit, C B H W Lamers, and R A van Hogezand
Gut 2002; 51: 26-29. [Abstract] [Full text] [PDF] [Request Permissions]  

Inflammatory bowel disease
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

B R Yacyshyn, W Y Chey, J Goff, B Salzberg, R Baerg, A L Buchman, J Tami, R Yu, E Gibiansky, and W R Shanahan
Gut 2002; 51: 30-36. [Abstract] [Full text] [PDF] [Request Permissions]